Double maintains 3 strategies that include PCRX - Pacira Biosciences, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
WBTN | 45.66% | $1.16B | -57.71% | 0.00% |
PUBM | 44.43% | $560.56M | -49.40% | 0.00% |
FIVN | 43.09% | $2.11B | -48.64% | 0.00% |
AVD | 42.68% | $118.03M | -53.20% | 0.73% |
MITK | 39.18% | $439.69M | -30.38% | 0.00% |
NATR | 32.64% | $269.57M | -5.89% | 0.00% |
MTUS | 30.80% | $565.63M | -42.11% | 0.00% |
JYNT | 29.75% | $154.71M | -42.75% | 0.00% |
AQN | 28.13% | $4.34B | -18.42% | 5.55% |
SEE | 27.55% | $4.67B | -18.53% | 2.51% |
MTW | 26.64% | $408.31M | -8.43% | 0.00% |
CDXS | 26.08% | $207.94M | -33.42% | 0.00% |
PRO | 25.82% | $892.45M | -39.95% | 0.00% |
TPST | 25.77% | $23.94M | -84.47% | 0.00% |
RPAY | 25.48% | $342.61M | -61.94% | 0.00% |
ALKS | 25.43% | $5.15B | +27.60% | 0.00% |
RWAY | 25.17% | $372.35M | -14.36% | 11.27% |
FIGS | 24.86% | $754.24M | -20.00% | 0.00% |
QTRX | 24.32% | $174.73M | -74.06% | 0.00% |
LOCO | 23.94% | $284.89M | -14.59% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DOCS | -35.59% | $10.97B | +146.21% | 0.00% |
QNTM | -34.57% | $21.04M | -55.31% | 0.00% |
TBRG | -26.26% | $368.07M | +164.86% | 0.00% |
CARG | -26.04% | $3.25B | +38.24% | 0.00% |
G | -25.90% | $7.67B | +27.42% | 1.43% |
ADMA | -25.11% | $4.58B | +111.92% | 0.00% |
SG | -21.30% | $1.79B | -52.08% | 0.00% |
EVH | -19.63% | $1.04B | -62.16% | 0.00% |
PRA | -17.83% | $1.19B | +58.17% | 0.00% |
VHC | -17.19% | $34.69M | +74.89% | 0.00% |
HRTG | -16.70% | $742.60M | +160.15% | 0.00% |
RCEL | -15.59% | $158.25M | -19.57% | 0.00% |
IAG | -15.44% | $3.60B | +42.27% | 0.00% |
CDLX | -14.80% | $104.48M | -78.53% | 0.00% |
PAY | -14.27% | $4.84B | +105.92% | 0.00% |
SLVM | -13.64% | $2.28B | -20.36% | 3.21% |
SBS | -13.30% | $13.91B | +31.04% | 3.15% |
VIRT | -11.20% | $3.52B | +74.46% | 2.35% |
EXPE | -10.83% | $21.13B | +46.51% | 0.24% |
MNST | -10.75% | $60.79B | +15.23% | 0.00% |
Yahoo
-- Early clinical data indicates that Pre-existing and treatment-induced anti-Ad5 neutralizing antibodies do not impact the safety and effectiveness of PCRX-201 – -- An oral presentation of the data to be featured at the ASGCT Annual Meeting -- BRISBANE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced new preliminary data which suggest
Finnhub
Pacira BioSciences, Inc. announced new preliminary data which suggests that clinical immunogenicity does not reduce sustained improvements in knee pain, stiffness and function provided by its gene...
Yahoo
BRISBANE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate in an analyst-led fireside chat at the following two healthcare conferences: 2025 RBC Capital Markets Global Healthcare Conference on Wednesday, May 21st at 8:30AM ET.2025 Jefferies Global Healthcare Conference on Wednesday, June 4th at 8:45AM
Finnhub
SAN DIEGO, May 13, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Pacira BioSciences, Inc. . ...
Yahoo
PCRX reports mixed first-quarter results, wherein earnings beat estimates but revenues miss the same. Exparel sales witness weak year-over-year growth.
Yahoo
Pacira BioSciences Inc (PCRX) reports robust Q1 performance with increased EXPAREL sales, strategic acquisitions, and a $300 million stock repurchase program.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NMFC | -<0.01% | - | - | 12.44% |
COR | <0.01% | $55.43B | +28.90% | 0.56% |
COCO | 0.01% | $1.96B | +31.80% | 0.00% |
ARCO | -0.01% | $1.56B | -29.25% | 3.25% |
STRA | 0.02% | $2.14B | -25.99% | 2.71% |
TDC | 0.03% | $2.21B | -31.92% | 0.00% |
AMT | 0.03% | $99.10B | +8.59% | 3.09% |
LCID | -0.06% | $8.21B | -6.60% | 0.00% |
BCSF | 0.06% | $1.01B | -4.23% | 10.80% |
PHM | -0.07% | $20.60B | -13.39% | 0.82% |
BARK | -0.07% | $220.39M | +1.61% | 0.00% |
TPC | 0.08% | $1.92B | +85.46% | 0.00% |
HOLX | -0.08% | $12.42B | -25.63% | 0.00% |
EGP | -0.10% | $8.97B | +2.39% | 3.18% |
CRTO | -0.10% | $1.54B | -22.38% | 0.00% |
CPRT | -0.10% | $60.83B | +15.37% | 0.00% |
TT | -0.12% | $94.19B | +30.07% | 0.82% |
PNTG | 0.13% | $1.01B | +31.24% | 0.00% |
BNED | 0.14% | $371.19M | -38.80% | 0.00% |
RVP | 0.14% | $22.45M | -23.47% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MMIN | -19.30% | $469.53M | 0.3% |
MUST | -18.17% | $403.58M | 0.23% |
BSMW | -17.90% | $102.62M | 0.18% |
TAXF | -17.87% | $500.81M | 0.29% |
SMMU | -17.46% | $822.53M | 0.35% |
PZA | -15.64% | $2.89B | 0.28% |
BILZ | -15.34% | $876.85M | 0.14% |
SCMB | -14.92% | $1.94B | 0.03% |
SHYD | -14.71% | $318.05M | 0.35% |
CMF | -13.91% | $3.57B | 0.08% |
ITM | -13.75% | $1.97B | 0.18% |
SHM | -13.63% | $3.37B | 0.2% |
TFLO | -13.36% | $7.06B | 0.15% |
FLMI | -13.33% | $649.76M | 0.3% |
JMUB | -13.07% | $2.80B | 0.18% |
BSSX | -13.05% | $75.11M | 0.18% |
VTEB | -12.95% | $35.64B | 0.03% |
CGSM | -12.92% | $658.61M | 0.25% |
MINO | -12.80% | $318.02M | 0.39% |
TFI | -12.78% | $3.15B | 0.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TDTF | -0.02% | $788.24M | 0.18% |
IBDT | 0.08% | $2.80B | 0.1% |
UTWO | -0.08% | $387.71M | 0.15% |
VGSH | -0.11% | $22.38B | 0.03% |
IBDZ | 0.13% | $324.49M | 0.1% |
DBE | -0.16% | $48.48M | 0.77% |
PCY | -0.17% | $1.17B | 0.5% |
UUP | 0.17% | $292.27M | 0.77% |
DBO | 0.18% | $182.54M | 0.77% |
FXC | -0.19% | $87.40M | 0.4% |
PFFR | -0.23% | $91.48M | 0.45% |
BSCT | -0.26% | $1.98B | 0.1% |
EWZS | 0.27% | $137.30M | 0.6% |
AGGH | 0.28% | $309.35M | 0.29% |
KCCA | 0.30% | $97.18M | 0.87% |
DIAL | 0.40% | $352.04M | 0.29% |
SHAG | -0.41% | $37.97M | 0.12% |
FXE | -0.44% | $525.40M | 0.4% |
CLSE | 0.46% | $177.11M | 1.44% |
IBDS | 0.49% | $3.01B | 0.1% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XPH | 27.38% | $136.58M | 0.35% |
PINK | 21.48% | $131.52M | 0.5% |
PBE | 19.53% | $214.12M | 0.58% |
FBT | 19.16% | $994.71M | 0.56% |
RZV | 18.99% | $200.54M | 0.35% |
IBB | 18.09% | $5.22B | 0.45% |
IWC | 17.95% | $766.88M | 0.6% |
CALF | 17.75% | $4.54B | 0.59% |
BSVO | 17.72% | $1.40B | 0.47% |
ARKG | 17.51% | $944.78M | 0.75% |
VIOV | 17.49% | $1.27B | 0.1% |
IHE | 17.40% | $550.13M | 0.39% |
XBI | 17.39% | $4.85B | 0.35% |
BBH | 17.13% | $327.42M | 0.35% |
YYY | 17.08% | $538.81M | 3.25% |
IWN | 17.05% | $11.10B | 0.24% |
FTSL | 16.92% | $2.37B | 0.87% |
RWJ | 16.84% | $1.51B | 0.39% |
EES | 16.63% | $588.44M | 0.38% |
JAAA | 16.62% | $20.90B | 0.2% |
Current Value
$25.641 Year Return
Current Value
$25.641 Year Return